CLIA Kit for Angiotensin I Converting Enzyme (ACE)

CD143; ACE1; DCP1; ACEI; ACE-I; Kininase II; Angiotensin-Converting Enzyme; Peptidyl-Dipeptidase A; Dipeptidyl Carboxypeptidase 1; Angiotensin-converting enzyme, soluble form

  • CLIA Kit for Angiotensin I Converting Enzyme (ACE) Packages (Simulation)
  • CLIA Kit for Angiotensin I Converting Enzyme (ACE) Packages (Simulation)
  • CLIA Kit for Angiotensin I Converting Enzyme (ACE) Results demonstration
  • SCA004Mu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Angiotensin I Converting Enzyme (ACE)

This assay has high sensitivity and excellent specificity for detection of Angiotensin I Converting Enzyme (ACE).
No significant cross-reactivity or interference between Angiotensin I Converting Enzyme (ACE) and analogues was observed.

Recovery of the CLIA Kit for Angiotensin I Converting Enzyme (ACE)

Matrices listed below were spiked with certain level of recombinant Angiotensin I Converting Enzyme (ACE) and the recovery rates were calculated by comparing the measured value to the expected amount of Angiotensin I Converting Enzyme (ACE) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 98-105 101
EDTA plasma(n=5) 95-105 102
heparin plasma(n=5) 98-105 101

Precision of the CLIA Kit for Angiotensin I Converting Enzyme (ACE)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Angiotensin I Converting Enzyme (ACE) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Angiotensin I Converting Enzyme (ACE) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Angiotensin I Converting Enzyme (ACE)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Angiotensin I Converting Enzyme (ACE) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-95% 79-96% 86-101% 94-101%
EDTA plasma(n=5) 95-103% 95-102% 94-104% 78-97%
heparin plasma(n=5) 96-104% 80-102% 96-104% 82-91%

Stability of the CLIA Kit for Angiotensin I Converting Enzyme (ACE)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Angiotensin I Converting Enzyme (ACE)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Angiotensin I Converting Enzyme (ACE)

The microplate provided in this kit has been pre-coated with an antibody specific to Angiotensin I Converting Enzyme (ACE). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Angiotensin I Converting Enzyme (ACE). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Angiotensin I Converting Enzyme (ACE) level in the sample or standard.;

Related products

Catalog No. Organism species: Mus musculus (Mouse) Applications (RESEARCH USE ONLY!)
RPA004Mu03 Recombinant Angiotensin I Converting Enzyme (ACE) Positive Control; Immunogen; SDS-PAGE; WB.
RPA004Mu01 Recombinant Angiotensin I Converting Enzyme (ACE) Positive Control; Immunogen; SDS-PAGE; WB.
RPA004Mu02 Recombinant Angiotensin I Converting Enzyme (ACE) Positive Control; Immunogen; SDS-PAGE; WB.
PAA004Mu03 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE) WB; IHC; ICC; IP.
PAA004Mu01 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE) WB; IHC; ICC; IP.
PAA004Mu02 Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE) WB; IHC; ICC; IP.
LAA004Mu71 Biotin-Linked Polyclonal Antibody to Angiotensin I Converting Enzyme (ACE) WB; IHC; ICC.
SEA004Mu ELISA Kit for Angiotensin I Converting Enzyme (ACE) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA004Mu CLIA Kit for Angiotensin I Converting Enzyme (ACE) Chemiluminescent immunoassay for Antigen Detection.
LMA004Mu Multiplex Assay Kit for Angiotensin I Converting Enzyme (ACE) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK